Patent details

EP2613789 Title: SDF-1 BINDING NUCLEIC ACIDS AND THE USE THEREOF IN CANCER TREATMENT

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2613789
WO Application Number:
EP2011004554
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP11757776.7
WO Publication Number:
WO2012031773
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Germany (DE)
Publications:

Dates

Filing date:
09/09/2011
Grant date:
18/04/2018
EP Publication Date:
17/07/2013
WO Publication Date:
15/03/2012
Claims Translations Received Date:
Claims Translation B1 Received Date:
11/07/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
18/04/2018
EP B1 Publication Date:
18/04/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
08/09/2031
Lapsed By Expiration Date:
Patent Validated Date:
02/08/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
08/08/2022
 
 

 

Name:
TME Pharma AG
Address:
Max-Dohrn-Strasse 8-10, 10589, BERLIN, Germany (DE)

Historical Applicant/holder

From:
18/04/2018
To:
08/08/2022

 

Name:
Noxxon Pharma AG
Address:
Max-Dohrn-Strasse 8-10, 10589 BERLIN, Germany (DE)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
01/08/2018
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
PURSCHKE, Werner
Address:
13359 Berlin, Germany (DE)

2

Name:
JAROSCH, Florian
Address:
13469 Berlin, Germany (DE)

3

Name:
EULBERG, Dirk
Address:
10247 Berlin, Germany (DE)

4

Name:
KLUSSMANN, Sven
Address:
10585 Berlin, Germany (DE)

5

Name:
BUCHNER, Klaus
Address:
14197 Berlin, Germany (DE)

6

Name:
MAASCH, Christian
Address:
13509 Berlin, Germany (DE)

7

Name:
DINSE, Nicole
Address:
13409 Berlin, Germany (DE)

8

Name:
ZBORALSKI, Dirk
Address:
10965 Berlin, Germany (DE)

Priority

Priority Patent Number:
10009397
Priority Date:
09/09/2010
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 31/69; A61K 31/7088; A61K 31/7105; A61K 31/713; A61K 45/06; A61P 35/00; C12N 15/115;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
33/22
Publication date:
17/08/2022
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
33/18
Publication date:
08/08/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
17/18
Publication date:
18/04/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201816
Publication date:
18/04/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202201963A
Date Registered:
08/08/2022
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
TME Pharma AG
Address:
Max-Dohrn-Strasse 8-10, 10589, BERLIN, Germany (DE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/09/2025
Annual Fee Number:
15
Annual Fee Amount:
900 Euro
Last Annual Payment Date:
09/09/2024
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
800 Euro
Payer:
NLO
Filing date Document type Document Description Number of pages File Type
02/08/2018 Outgoing Correspondence Letter no formal defects 1 PDF /7/3/6/0/6/0800260637/docs/ep11757776.7_0_220669l271.pdf
11/07/2018 Claims First filed claims 9 PDF /7/3/6/0/6/0800260637/docs/ep11757776.7_1_claims20180711121459652.pdf
11/07/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /7/3/6/0/6/0800260637/docs/ep11757776.7_2_incomingcorrespondenceelectronic20180711121501488.pdf